GlobeNewsWire
29 Sept 2026, 12:36 UTC · 1h ago
Verdict
Headline takes no side. We score ICU +0.60 across three claims — strongly bullish.
+0.60strongly bullish
More positive than 77% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 1 new · 2 priced in
SeaStar Medical's CMO Kevin Chung will present on QUELIMMUNE at the PPETS conference from October 6-8, 2026.
Newannounced today, Sept 29, 2026
More positive than 46% of claims this week
QUELIMMUNE demonstrated a 77% survival rate compared to a 50% reduction in loss of life versus historical data.
Priced in
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
Near neutral — 98% of claims this week are stronger
Early SAVE Registry data from 21 patients showed a 71% survival rate at Day 90 with no device-related adverse events.
Priced inpublished in February 2026
Near neutral — 98% of claims this week are stronger
Which stocks this story touches
More positive than 77% of ticker scores this week
The company's CMO is presenting at a major symposium and the article highlights strong survival rates for its QUELIMMUNE therapy.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
4h ago
—
ICU hasn't traded since this ran. Last close $3.40 (Sep 28); the reaction starts at the next open.
ICU chart →
